Chronic kidney disease and premature ageing - Nature Reviews Nephrology
- ️Stenvinkel, Peter
- ️Tue Oct 07 2014
Carrero, J. J. et al. Telomere attrition is associated with inflammation, low fetuin-A levels and high mortality in prevalent haemodialysis patients. J. Intern. Med. 263, 302–312 (2008).
Kooman, J. P. et al. Out of control: accelerated aging in uremia. Nephrol. Dial. Transplant. 28, 48–54 (2013).
Stenvinkel, P. & Larsson, T. Chronic kidney disease: a clinical model of premature aging. Am. J. Kidney. Dis. 62, 339–351 (2013).
Amann, K. & Ritz, E. Cardiovascular abnormalities in ageing and in uraemia—only analogy or shared pathomechanisms? Nephrol. Dial. Transplant. 13 (Suppl. 7), 6–11 (1998).
Langen, R. C. et al. Triggers and mechanisms of skeletal muscle wasting in chronic obstructive pulmonary disease. Int. J. Biochem. Cell. Biol. 45, 2245–2256 (2013).
von Haehling, S. et al. Muscle wasting in heart failure: an overview. Int. J. Biochem. Cell. Biol. 45, 2257–2265 (2013).
Pathai, S. et al. Accelerated biological ageing in HIV-infected individuals in South Africa: a case-control study. AIDS 27, 2375–2378 (2013).
Crowson, C. S. et al. Could accelerated aging explain the excess mortality in patients with seropositive rheumatoid arthritis? Arthritis Rheum. 62, 378–382 (2010).
Karatsoreos, I. N. & McEwen, B. S. Resilience and vulnerability: a neurobiological perspective. F1000 Prime Rep. 5, 13 (2013).
Parrella, E. & Longo, V. D. Insulin/IGF-I and related signaling pathways regulate aging in nondividing cells: from yeast to the mammalian brain. Scientific World Journal 10, 161–177 (2010).
Eijkelenboom, A. & Burgering, B. M. FOXOs: signaling integrators for homeostasis maintenance. Nat. Rev. Mol. Cell. Biol. 14, 83–97 (2013).
Kirkwood, T. B. Understanding ageing from an evolutionary perspective. J. Intern. Med. 2008 263, 117–127 (2008).
Briet, M. et al. Arterial stiffness and pulse pressure in CKD and ESRD. Kidney Int. 82, 388–400 (2012).
Carracedo, J. et al. Cellular senescence determines endothelial cell damage induced by uremia. Exp. Gerontol. 48, 766–773 (2013).
Ito, K. et al. Geroprotectors as a novel therapeutic strategy for COPD, an accelerating aging disease. Int. J. Chron. Obstruct. Pulmon. Dis. 7, 641–652 (2012).
Georgin-Lavialle, S. et al. The telomere/telomerase system in autoimmune and systemic immune-mediated diseases. Autoimmun. Rev. 9, 646–651 (2010).
Shiels, P. G. Improving precision in investigating aging: why telomeres can cause problems. J. Gerontol. 65, 789–791 (2010).
Gingell-Littlejohn, M. et al. Pre-transplant CDKN2A expression in kidney biopsies predicts renal function and is a future component of donor scoring criteria. PLoS ONE 8, e68133 (2013).
Acquaah-Mensah, G. K. et al. Suppressed expression of T-box transcription factors is involved in senescence in chronic obstructive pulmonary disease. PLoS Comput. Biol. 8, e1002597 (2012).
Baker, G. T. 3rd & Sprott, R. L. Biomarkers of aging. Exp. Gerontol. 23, 223–239 (1988).
Der, G. et al. Is telomere length a biomarker for aging: cross-sectional evidence from the west of Scotland? PLoS ONE 7, e45166 (2012).
Gabai, V. L. et al. HSP72 depletion suppresses γH2AX activation by genotoxic stresses via p53/p21 signaling. Oncogene 29, 1952–1962 (2010).
Goldman, R. D. et al. Accumulation of mutant lamin A causes progressive changes in nuclear architecture in Hutchinson-Gilford progeria syndrome. Proc. Natl Acad. Sci. USA 101, 8963–8968 (2004).
Himmelfarb, J. et al. The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int. 62, 1524–1538 (2002).
Ghoorah, K. et al. Increased cardiovascular risk in patients with chronic obstructive pulmonary disease and the potential mechanisms linking the two conditions: a review. Cardiol. Rev. 21, 196–202 (2013).
Lewis, W. Atherosclerosis in AIDS: potential pathogenetic roles of antiretroviral therapy and HIV. J. Mol. Cell. Cardiol. 32, 2115–2129 (2000).
van Breukelen-van der Stoep, D. F. et al. Cardiovascular risk in rheumatoid arthritis: how to lower the risk? Atherosclerosis 231, 163–172 (2013).
Gómez, L. A. & Hagen, T. M. Age-related decline in mitochondrial bioenergetics: does supercomplex destabilization determine lower oxidative capacity and higher superoxide production? Semin. Cell Dev. Biol. 23, 758–767 (2012).
Sukhanov, S. et al. Angiotensin II, oxidative stress and skeletal muscle wasting. Am. J. Med. Sci. 342, 143–147 (2011).
Hybertson, B. M. et al. Oxidative stress in health and disease: the therapeutic potential of Nrf2 activation. Mol. Aspects Med. 32, 234–246 (2011).
Grimes, K. M. et al. And the beat goes on: maintained cardiovascular function during aging in the longest-lived rodent, the naked mole-rat. Am. J. Physiol. Heart. Circ. Physiol. 307, H289–H291 (2014).
De Waal, E. M. et al. Elevated protein carbonylation and oxidative stress do not affect protein structure and function in the long-living naked-mole rat: a proteomic approach. Biochem. Biophys. Res. Commun. 434, 815–819 (2013).
Sosnowska, D. et al. A heart that beats for 500 years: age-related changes in cardiac proteasome activity, oxidative protein damage and expression of heat shock proteins, inflammatory factors, and mitochondrial complexes in Arctica islandica, the longest-living noncolonial animal. J. Gerontol. A Biol. Sci. Med. Sci. http://dx.doi.org/10.1093/gerona/glt201.
Stevenson, K. S. et al. Breath ethane peaks during a single haemodialysis session and is associated with time on dialysis. J. Breath. Res. 2, 02600 (2008).
Mutsaers, H. A. et al. Uremic toxins inhibit renal metabolic capacity through interference with glucuronidation and mitochondrial respiration. Biochim. Biophys. Acta. 1832, 142–150 (2013).
Barnes, P. J. New anti-inflammatory targets for chronic obstructive pulmonary disease. Nat. Rev. Drug Discov. 12, 543–559 (2013).
Couillard, A. & Prefaut, C. From muscle disuse to myopathy in COPD: potential contribution of oxidative stress. Eur. Resp. J. 26, 703–719 (2005).
Rubattu, S. et al. Pathogenesis of chronic cardiorenal syndrome: is there a role for oxidative stress? Int. J. Mol. Sci. 14, 23011–23032 (2013).
Ye, Y. et al. Effect of antioxidant vitamin supplementation on cardiovascular outcomes: a meta-analysis of randomized controlled trials. PLoS ONE 8, e56803 (2013).
Coombes, J. S. & Fassett, R. G. Antioxidant therapy in hemodialysis patients: a systematic review. Kidney Int. 81, 233–246 (2012).
Tsakiri, E. N. et al. Proteasome dysfunction in Drosophila signals to an Nrf2-dependent regulatory circuit aiming to restore proteostasis and prevent premature aging. Aging Cell 12, 802–813 (2013).
Kim, E. B. et al. Genome sequencing reveals insights into physiology and longevity of the naked mole rat. Nature 479, 223–227 (2011).
Kim, H. J. & Vaziri, N. D. Contribution of impaired Nrf2-Keap1 pathway to oxidative stress and inflammation in chronic renal failure. Am. J. Physiol. Renal Physiol. 298, F662–F671 (2010).
Zhang, H. S. et al. Nrf2 is involved in inhibiting Tat-induced HIV-1 long terminal repeat transactivation. Free Radic. Biol. Med. 47, 261–268 (2009).
de Zeeuw, D. et al. Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease. N. Engl. J. Med. 369, 2492–2503 (2013).
Aminzadeh, M. A. et al. Role of impaired Nrf2 activation in the pathogenesis of oxidative stress and inflammation in chronic tubulo-interstitial nephropathy. Nephrol. Dial. Transplant. 28, 2038–2045 (2013).
Cochemé, H. M. et al. Measurement of H2O2 within living Drosophila during aging using a ratiometric mass spectrometry probe targeted to the mitochondrial matrix. Cell. Metab. 13, 340–350 (2011).
Licastro, F. et al. Innate immunity and inflammation in ageing: a key for understanding age-related diseases. Immun. Ageing 2, 8 (2005).
Kato, S. et al. Aspects of immune dysfunction in end-stage renal disease. Clin. J. Am. Soc. Nephrol. 3, 1526–1533 (2008).
von Haehling, S. et al. Inflammatory biomarkers in heart failure revisited: much more than innocent bystanders. Heart Fail. Clin. 5, 549–560 (2009).
Jurk, D. et al. Chronic inflammation induces telomere dysfunction and accelerates ageing in mice. Nat. Commun. 2, 4172 (2014).
Campis, J. et al. Cellular senescence: when bad things happen to good cells. Nat. Rev. Mol. Cell. Biol. 8, 729–740 (2007).
Shiels, P. G. et al. Accelerated telomere attrition is associated with relative household income, diet and inflammation in the pSoBid cohort. PLoS ONE 6, e22521 (2011).
Betjes, M. G. et al. Loss of renal function causes premature aging of the immune system. Blood Purif. 36, 173–178 (2013).
Meuwese, C. L. et al. Recent insights in inflammation-associated wasting in patients with chronic kidney disease. Contrib. Nephrol. 171, 120–126 (2011).
Shanahan, C. M. Mechanisms of vascular calcification in CKD—evidence for premature ageing? Nat. Rev. Nephrol. 9, 661–670 (2013).
Matsuoka, S. et al. The relationship between small pulmonary vascular alteration and aortic atherosclerosis in chronic obstructive pulmonary disease: quantitative CT analysis. Acad. Radiol. 18, 40–46 (2011).
Paccou, J. et al. Vascular calcification in rheumatoid arthritis: prevalence, pathophysiological aspects and potential targets. Atherosclerosis 224, 283–290 (2012).
Carrero, J. J. & Stenvinkel, P. Inflammation in end-stage renal disease-what have we learned in 10 years? Semin. Dial. 23, 498–509 (2010).
McGuinness, D. et al. Socio-economic status is associated with epigenetic differences in the pSoBid cohort. Int. J. Epidemiol. 41, 151–160 (2012).
Salminen, A. et al. Activation of innate immunity system during aging: NF-κB signaling is the molecular culprit of inflamm-aging. Ageing Res. Rev. 7, 83–105 (2008).
Mendelsohn, A. R. & Larrick, J. W. Dietary modification of the microbiome affects risk for cardiovascular disease. Rejuvenation Res. 16, 241–244 (2013).
Cabreiro, F. et al. Metformin retards aging in C. elegans by altering microbial folate and methionine metabolism. Cell 153, 228–239 (2013).
Stenvinkel, P. & Johnson, R. J. Kidney biomimicry—a rediscovered scientific field that could provide hope to patients with kidney disease. Arch. Med. Res. 44, 584–590 (2013).
Kooman, J. P. et al. 'Time and time again': oscillatory and longitudinal time patterns in dialysis patients. Kidney Blood Press. Res. 35, 534–548 (2012).
Russcher, M., et al. Long-term effects of melatonin on quality of life and sleep in hemodialysis patients (Melody study): a randomized controlled trial. Br. J. Clin. Pharmacol. 76, 668–679 (2013).
Parish, J. M. Sleep-related problems in common medical conditions. Chest 135, 563–572 (2009).
Vink, E. E. et al. Sympathetic hyperactivity in chronic kidney disease: pathophysiology and (new) treatment options. Curr. Hypertens. Rep. 15, 95–101 (2013).
van Gestel, A. J. et al. Sympathetic overactivity and cardiovascular disease in patients with chronic obstructive pulmonary disease (COPD). Discov. Med. 14, 359–368 (2012).
Lymperopoulos, A. et al. Adrenergic nervous system in heart failure: pathophysiology and therapy. Circ. Res. 113, 739–753 (2013).
van Gurp, P. J. et al. Sympathetic nervous system function in HIV-associated adipose redistribution syndrome. AIDS 20, 773–775 (2006).
Evrengül, H. et al. Heart rate variability in patients with rheumatoid arthritis. Rheumatol. Int. 24, 198–202 (2004).
Seals, D. R. et al. The aging cardiovascular system: changes in autonomic function at rest and in response to exercise. Int. J. Sport. Nutr. Exerc. Metab. 11, S189–S195 (2011).
Kooman, J. P. et al. Blood pressure during the interdialytic period in haemodialysis patients: estimation of representative blood pressure values. Nephrol. Dial. Transplant. 7, 917–923 (1992).
Schillaci, G. et al. Symmetric ambulatory arterial stiffness index and 24-h pulse pressure in HIV infection: results of a nationwide cross-sectional study. J. Hypertens. 31, 560–567 (2013).
Kario, K. et al. Sleep-predominant lowering of ambulatory blood pressure by bedtime inhalation of a novel muscarinic M3 receptor antagonist: a new “bronchoantihypertensive” strategy targeting the lung in hypertension with chronic obstructive pulmonary disease. Hypertens. Res. 31, 817–821 (2008).
de la Sierra, A. et al. Prevalence and factors associated with circadian blood pressure patterns in hypertensive patients. Hypertension 53, 466–472 (2009).
Toprak, A. et al. Night-time blood pressure load is associated with higher left ventricular mass index in renal transplant recipients. J. Hum.Hypertens. 17, 239–244 (2003).
Bacurau, A. V. et al. Sympathetic hyperactivity differentially affects skeletal muscle mass in developing heart failure: role of exercise training. J. Appl. Physiol. (1985) 106, 1631–1640 (2009).
Pavlov, V. A. & Tracey, K. J. The vagus nerve and the inflammatory reflex—linking immunity and metabolism. Nat. Rev. Endocrinol. 8, 743–754 (2012).
Bruchfeld, A. et al. Whole blood cytokine attenuation by cholinergic agonists ex vivo and relationship to vagus nerve activity in rheumatoid arthritis. J. Intern. Med. 268, 94–101 (2010).
Rollo, C. D. Aging and the mammalian regulatory triumvirate. Aging Dis. 1, 105–138 (2010).
Mendelsohn, A. R. & Larrick, J. W. Sleep facilitates clearance of metabolites from the brain: glymphatic function in aging and neurodegenerative diseases. Rejuvenation Res. 16, 518–523 (2013).
Bonaz, B. et al. Vagus nerve stimulation: from epilepsy to the cholinergic anti-inflammatory pathway. Neurogastroenterol. Motil. 25, 208–221 (2013).
Satapathy, S. K. et al. Galantamine alleviates inflammation and other obesity-associated complications in high-fat diet-fed mice. Mol. Med. 17, 599–606 (2011).
Yuasa, S., et al. Treatment responses and their predictors in patients with rheumatoid arthritis treated with biological agents. J. Med. Invest. 60, 77–90 (2013).
Yoshida, S. et al. Infliximab, a TNF-α inhibitor, reduces 24-h ambulatory blood pressure in rheumatoid arthritis patients. J. Hum. Hypertens. 28, 165–169 (2014).
Zhao, P. et al. Evening versus morning dosing regimen drug therapy for hypertension. Cochrane Database of Systematic Reviews, Issue 10. Art. No.: CD004184.
Perl, J. et al. Sleep disorders in end-stage renal disease: 'markers of inadequate dialysis'? Kidney Int. 70, 1687–1693 (2006).
Salminen, A. & Kaarniranta, K. Insulin/IGF-1 paradox of aging: regulation via AKT/IKK/NF-κB signaling. Cell Signal. 22, 573–577 (2010).
Lapierre, L. R. & Hansen, M. Lessons from C. elegans: signaling pathways for longevity. Trends Endocrinol. Metab. 23, 637–644 (2012).
Schiaffino, S. et al. Mechanisms regulating skeletal muscle growth and atrophy. FEBS J. 280, 4294–4314 (2013).
Doria, A. et al. Autophagy in human health and disease. N. Engl. J. Med. 368, 1845 (2013).
Salminen, A. & Kaarniranta, K. Regulation of the aging process by autophagy. Trends. Mol. Med. 15, 217–224 (2009).
Salminen, A. et al. Inflammaging: disturbed interplay between autophagy and inflammasomes. Aging (Albany NY) 4, 166–175 (2012).
Roseboom, T. et al. The Dutch famine and its long-term consequences for adult health. Early Hum. Dev. 82, 485–491 (2006).
Katti, G. et al. Cardiovascular and diabetes mortality determined by nutrition during parents' and grandparents' slow growth period. Eur. J. Hum. Genet. 10, 682–688 (2002).
Thaler, R. et al. Homocysteine suppresses the expression of the collagen cross-linker lysyloxidase involving IL-6, Fli1, and epigenetic DNA methylation. J. Biol. Chem. 286, 5578–5588 (2010).
Stenvinkel, P. et al. Impact of inflammation on epigenetic DNA methylation—a novel risk factor for cardiovascular disease? J. Intern. Med. 261, 488–499 (2007).
Wang, X. H. & Mitch, W. E. Muscle wasting from kidney failure—a model for catabolic conditions. Int. J. Biochem. Cell. Biol. 45, 2230–2238 (2013).
McIntire, K. L. et al. Acute uremia suppresses leucine-induced signal transduction in skeletal muscle. Kidney Int. 85, 374–382 (2014).
Sandri, M. et al. Signalling pathways regulating muscle mass in ageing skeletal muscle. The role of the IGF1-Akt-mTOR-FoxO pathway. Biogerontology 14, 303–323 (2013).
Reed, S. A. et al. Inhibition of FoxO transcriptional activity prevents muscle fiber atrophy during cachexia and induces hypertrophy. FASEB J. 26, 987–1000 (2012).
Hussain, S. N. & Sandri, M. Role of autophagy in COPD skeletal muscle dysfunction. J. Appl. Physiol. (1985) 114, 1273–1281 (2013).
Guo, Y. et al. Autophagy in locomotor muscles of patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 118, 1313–1320 (2013).
Castellano, G. et al. The GH/IGF-1 axis and heart failure. Curr. Cardiol. Rev. 5, 203–215 (2009).
Stark, M. The sandpile model: optimal stress and hormesis. Dose Response 10, 66–74 (2012).
Johansen, K. L. et al. Effects of resistance exercise training and nandrolone decanoate on body composition and muscle function among patients who receive hemodialysis: a randomized, controlled trial. J. Am. Soc. Nephrol. 17, 2307–2314 (2006).
Fouque, D. et al. Recombinant human insulin-like growth factor-1 induces an anabolic response in malnourished CAPD patients. Kidney Int. 57, 646–654 (2000).
Kotzmann, H. et al. Differential effects of growth hormone therapy in malnourished hemodialysis patients. Kidney Int. 60, 1578–1585 (2001).
Blagosklonny, M. V. Calorie restriction. Decelerating mTOR-driven aging from cells to organisms (including humans). Cell Cycle 9, 683–688 (2010).
Mendelsohn, A. R. & Larrick, J. W. Rapamycin as an antiaging therapeutic? Targeting mammalian target of rapamycin to treat Hutchinson-Gilford progeria and neurodegenerative diseases. Rejuvenation Res. 14, 437–441 (2011).
Ikizler, T. A. et al. Prevention and treatment of protein energy wasting in chronic kidney disease patients: a consensus statement by the International Society of Renal Nutrition and Metabolism. Kidney Int. 84, 1096–1107 (2013).
Charansonney, O. L. Physical activity and aging: a life-long story. Discov. Med. 12, 177–185 (2011).
Sanchis-Gomar, F. Sestrins: novel antioxidant and AMPK-modulating functions regulated by exercise? J. Cell. Physiol. 228, 1647–1650 (2013).
Ribeiro, F. et al. Should all patients with COPD be exercise trained? J. Appl. Physiol. (1985) 114, 1300–1308 (2013).
Kuro-o, M. A potential link between phosphate and aging-lessons from Klotho-deficient mice. Mech. Ageing Dev. 131, 270–275 (2010).
Hu, M. C. et al. Fibroblast growth factor 23 and Klotho: physiology and pathophysiology of an endocrine network of mineral metabolism. Annu. Rev. Physiol. 75, 503–533 (2013).
Dai, X. Y. et al. Phosphate-induced autophagy counteracts vascular calcification by reducing matrix vesicle release. Kidney Int. 83, 1042–1051 (2013).
Ketteler, M. et al. Phosphate: a novel cardiovascular risk factor. Eur. Heart J. 34, 1099–1010 (2013).
Merideth, M. A. et al. Phenotype and course of Hutchinson-Gilford progeria syndrome. N. Engl. J. Med. 358, 592–604 (2008).
Warren, D. T. & Shanahan, C. M. Defective DNA-damage repair induced by nuclear lamina dysfunction is a key mediator of smooth muscle cell aging. Bioch. Soc. Trans. 39, 1780–1785 (2011).
Villa-Bellasto, R. et al. Defective extracellular pyrophosphate metabolism promotes vascular calcification in a mouse model of Hutchingson-Gilford progeria syndrome that is ameliorated on pyrophosphate treatment. Circulation 127, 2442–2451 (2013).
Persy, V. P. & McKee, M. D. Prevention of vascular calcification: is pyrophosphate therapy a solution? Kidney Int. 79, 490–493 (2011).
O'Neill, W. C. et al. Treatment with pyrophosphate inhibits uremic vascular calcification. Kidney Int. 79, 512–517 (2011).
Bhan, I. Phosphate management in chronic kidney disease. Curr. Opin. Nephrol. Hypertens. 23, 174–179 (2014).
Shrikrishna, D. et al. Renin-angiotensin system blockade: a novel therapeutic approach in chronic obstructive pulmonary disease. Clin. Sci. (Lond.) 123, 487–498 (2012).
Flammer, A. J. et al. Angiotensin-converting enzyme inhibition improves vascular function in rheumatoid arthritis. Circulation 117, 2262–2269 (2008).
Boccara, F. et al. HIV protease inhibitors activate the adipocyte renin angiotensin system. Antivir. Ther. 15, 363–375 (2010).
Yoshida, T. et al. Molecular mechanisms and signaling pathways of angiotensin II-induced muscle wasting: potential therapeutic targets for cardiac cachexia. Int. J. Biochem. Cell. Biol. 45, 2322–2332 (2013).
Titze, J. et al. Spooky sodium balance. Kidney Int. 85, 759–767 (2014).
Wiig, H. et al. Immune cells control skin lymphatic electrolyte homeostasis and blood pressure. J. Clin. Invest. 123, 2803–2815 (2013).
Machnik, A. et al. Macrophages regulate salt-dependent volume and blood pressure by a vascular endothelial growth factor-C-dependent buffering mechanism. Nat. Med. 15, 545–552 (2009).
Kleinewietfeld, M. et al. Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells. Nature 496, 518–522 (2013).
Drüeke, T. B. & Massy, Z. A. Circulating Klotho levels: clinical relevance and relationship with tissue Klotho expression. Kidney Int. 83, 13–15 (2013).
Lindberg, K. et al. The kidney is the principal organ mediating klotho effects. J. Am. Soc. Nephrol. http://dx.doi.org/10.1681/ASN.2013111209.
Razzaque, M. S. The FGF23-Klotho axis: endocrine regulation of phosphate homeostasis. Nat. Rev. Endocrinol. 5, 611–619 (2009).
Desjardins, L. et al. European Uremic Toxin (EUTox) Work Group. FGF23 is independently associated with vascular calcification but not bone mineral density in patients at various CKD stages. Osteoporos. Int. 23, 2017–2025 (2012).
Sun, C. Y. et al. Suppression of Klotho expression by protein-bound uremic toxins is associated with increased DNA methyltransferase expression and DNA hypermethylation. Kidney Int. 81, 640–650 (2012).
Tang, C. et al. Downregulation of Klotho expression by dehydration. Am. J. Physiol. Renal Physiol. 301, F745–F750 (2011).
Zhou, X., Chen, K., Lei, H. & Sun, Z. Klotho gene deficiency causes salt-sensitive hypertension via monocyte chemotactic protein-1/CC chemokine receptor 2-mediated inflammation. J. Am. Soc Nephrol. http://dx.doi.org/101681/ASN.2013101033.
Balasubramanian, P. & Longo, V. D. Linking Klotho, Nrf2, MAP kinases and aging. Aging (Albany NY) 2, 632–633 (2010).
Jeong, S. J. et al. Plasma klotho levels were inversely associated with subclinical carotid atherosclerosis in HIV-infected patients receiving combined antiretroviral therapy. AIDS Res. Hum. Retroviruses 29, 1575–1581 (2013).
Witkowski, J. M. et al. Klotho—a common link in physiological and rheumatoid arthritis-related aging of human CD4+ lymphocytes. J. Immunol. 178, 771–777 (2007).
Semba, R. D. et al. Plasma klotho and cardiovascular disease in adults. J. Am. Geriatr. Soc. 59, 1596–1601 (2011).
Semba, R. D. et al. Relationship of low plasma klotho with poor grip strength in older community-dwelling adults: the InCHIANTI study. Eur. J. Appl. Physiol. 112, 1215–1220 (2012).
Dobnig, H. et al. Independent association of low serum 25-hydroxyvitamin D and 1, 25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch. Intern. Med. 168, 1340–1349 (2008).
Richards, J. B. et al. Higher serum vitamin D concentrations are associated with longer leukocyte telomere length in women. Am. J. Clin. Nutr. 86, 1420–1425 (2007).
Lee, S. Y. et al. 25-hydroxyvitamin D levels and vascular calcification in predialysis and dialysis patients with chronic kidney disease. Kidney Blood Press. Res. 3, 349–354 (2012).
Argacha, J. F. et al. Vitamin D deficiency-induced hypertension is associated with vascular oxidative stress and altered heart gene expression. J. Cardiovasc. Pharmacol. 58, 65–71 (2011).
McGuinness, D. et al. Sirtuins, bioageing, and cancer. J. Aging Res. 2011, 235754 (2011).
Gomes, A. P. et al. Declining NAD+ induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging. Cell 155, 1624–1638 (2013).
Saldanha, J. F. et al. Resveratrol: why is it a promising therapy for chronic kidney disease patients? Oxid. Med. Cell. Longev. 2013, 963217 (2013).
Momchilova, A. et al. Resveratrol alters the lipid composition, metabolism and peroxide level in senescent rat hepatocytes. Chem. Biol. Interact. 207, 74–80 (2014).
Kramer, H. Dietary patterns, calories and kidney disease. Adv. Chr. Kidney Dis. 20, 135–140 (2013).
Wolfe, R. A. et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N. Engl. J. Med. 341, 1725–1730 (1999).
Ciancolo, G. et al. Importance of vascular calcification in kidney transplant recipients. Am. J. Nephrol. 39, 418–426 (2014).
Bahous, S. A. et al. Aortic pulse wave velocity in renal transplant patients. Kidney Int. 66, 1486–1492 (2004).
van den Ham, E. C. et al. Similarities in skeletal muscle strength and exercise capacity between renal transplant and hemodialysis patients. Am. J. Transplant. 5, 1957–1965 (2005).
van den Ham, E. C. et al. The functional, metabolic, and anabolic responses to exercise training in renal transplant and hemodialysis patients. Transplantation 83, 1059–1068 (2007).
Vostálová, J. et al. Stabilization of oxidative stress 1 year after kidney transplantation: effect of calcineurin immunosuppressives. Ren. Fail. 34, 952–959 (2012).
Nafar, M. Oxidative stress in kidney transplantation: causes, consequences, and potential treatment. Iran. J. Kidney Dis. 5, 357–372 (2011).
Kunlin, J. Modern biological theories of aging. Aging Dis. 1, 72–74 (2010).
Crowley, L. E. et al. Tissue advanced glycation end product deposition after kidney transplantation. Nephron Clin. Pract. 124, 54–59 (2013).
Mansell, H. et al. Evidence of enhanced systemic inflammation in stable kidney transplant recipients with low Framingham risk scores. Clin. Transplant. 27, E391–E399 (2013).
Krajisnik, T. et al. Parathyroid klotho and FGF-receptor 1 expression decline with renal function in hyperparathyroid patients with chronic kidney disease and kidney transplant recipients. Kidney Int. 78, 1024–1032 (2010).
Tataranni, T. et al. Rapamycin-induced hypophosphatemia and insulin resistance are associated with mTORC2 activation and klotho expression. Am. J. Transpl. 11, 1656–1664 (2011).
Getliffe, K. M. et al. Lymphocyte telomere dynamics and telomerase activity in inflammatory bowel disease: effect of drugs and smoking. Aliment. Pharmacol. Ther. 21, 121–131 (2005).
Bauer, M. E. et al. The role of stress factors during aging of the immune system. Ann. NY Acad. Sci. 1153, 139–152 (2009).
Muteliefu, G. et al. Indoxyl sulfate promotes vascular smooth muscle cell senescence with upregulation of p53, p21, and prelamin A through oxidative stress. Am. J. Physiol. Cell. Physiol. 303, C126–C134 (2012).
Ragnauth, C. D. et al. Prelamin-A acts to accelerate smooth muscle cell senescence and is a novel biomarker of human vascular aging. Circulation 121, 2200–2210 (2010).
El Assar, M. et al. Oxidative stress and vascular inflammation in aging. Free Radic. Biol. Med. 65, 380–401 (2013).
Anthony, D. F. & Shiels, P. G. Exploiting paracrine mechanisms of tissue regeneration to repair damaged organs. Transpl. Proc. 2, 10 (2013).
Martini, S. et al. Integrative biology identifies shared transcriptional networks in CKD. J. Am. Soc. Nephrol. http://dx.doi.org/10.1681/ASN.2013080906.
Bousquet, J. et al. Systems medicine and integrated care to combat chronic noncommunicable diseases. Genome Med. 3, 43 (2011).
Horvath, S. DNA methylation age of human tissues and cell types. Genome Biol. 14, R115 (2013).
Finkel, T. Radical medicine: treating ageing to cure disease. Nat. Rev. Mol. Cell. Biol. 6, 971–976 (2005).
Katsimpardi, L. et al. Vascular and neurogenic rejuvenation of the aging mouse brain by young systemic factors. Science 344, 630–634 (2014).
Sinha, M. et al. Restoring systemic GDF11 levels reverses age-related dysfunction in mouse skeletal muscle. Science 344, 649–652 (2014).
Hsu, S. C. et al. Testosterone increases renal anti-aging klotho gene expression via the androgen receptor-mediated pathway. Biochem. J. http://dx.doi.org/10.1042/BJ20140739.